HEALIOS K.K.

4593・Growth Market・Pharmaceuticals

Official website

HEALIOS K.K.

4593・Growth Market・Pharmaceuticals

Official website

HEALIOS K.K.4593

Reference Indicators

Market Cap

351¥100M

P/E (Forecast)

—

P/B

6.2x

Dividend Yield (Forecast)

0.00%

ROE

-45.3%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	41	90	121	560	104
Cost of Sales	—	—	13	128	218
Gross Profit	41	90	109	432	-114
SG&A Expenses	1,722	1,449	1,184	1,374	1,265
Operating Income	-5,384	-5,179	-3,379	-2,843	-3,340
Pre-tax Income	-4,462	-5,330	-3,626	-4,061	-2,126
Income Taxes	450	-160	187	166	103
Net Income	-4,910	-5,169	-3,823	-4,235	-2,217
EBITDA	-5,122	-4,793	-3,155	-2,546	-3,065
Gross Margin	100.0%	100.0%	90.1%	77.1%	-109.6%
Operating Margin	-13131.7%	-5754.4%	-2792.6%	-507.7%	-3211.5%
ROA	-20.5%	-34.4%	-25.2%	-29.8%	-13.0%
ROE	-56.8%	-118.0%	-99.1%	-205.3%	-45.3%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
研究開発部門	0	0	0.0%
管理部門	0	0	0.0%